US 9549943
A3 adenosine receptor ligands for use in treatment of a sexual dysfunction
granted A61KA61K31/4745A61K31/7076
Quick answer
US patent 9549943 (A3 adenosine receptor ligands for use in treatment of a sexual dysfunction) held by CAN-FITE BIOPHARMA LTD. expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAN-FITE BIOPHARMA LTD.
- Grant date
- Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4745, A61K31/7076, A61P, A61P15/00